Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For Venous Thromboembolism Following Total Joint Arthroplasty - A Multi-center Prospective Randomized Control Trial

Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For Venous Thromboembolism Following Total Joint Arthroplasty - A Multi-center Prospective Randomized Control Trial

Principal Investigator

Sponsor

University of Miami

Our primary objective is to evaluate the efficacy of two different regimens, 81mg aspirin daily vs 81 mg aspirin BID, in providing prophylaxis against symptomatic thromboembolic events, in patients undergoing total joint arthroplasty.

This study is currently enrolling.